Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Connie MatsuiDirector | Sutro BiopharmaSTRO | Open-market buy | 25/10/15 | 25/10/16 | 50,000 sh | $0.80 | $40,000 | No record |
Sutro BiopharmaSTRO | Open-market buy | 25/10/15 | 25/10/16 | 19,750 sh | $0.81 | $15,997.5 | No record | |
Jane ChungCEO | Sutro BiopharmaSTRO | Open-market buy | 25/10/15 | 25/10/16 | 12,500 sh | $0.80 | $10,000 | +11.3% |
Hans-Peter GerberChief Scientific Officer | Sutro BiopharmaSTRO | Open-market buy | 25/10/15 | 25/10/16 | 17,000 sh | $0.80 | $13,600 | +31.0% |
David PaulingChief Admin. Ofcr. & GC | Sutro BiopharmaSTRO | Open-market buy | 25/10/15 | 25/10/16 | 12,504 sh | $0.80 | $10,003.2 | +21.1% |
Nicki VasquezChief Port. Strat & Alnce Ofcr | Sutro BiopharmaSTRO | Open-market sale10b5-1 plan | 24/01/29 | 24/01/31 | 12,185 sh | $5.00 | $60,925 | −48.8% |
Brunilda ShtyllaChief Business Officer | Sutro BiopharmaSTRO | Open-market sale | 23/08/28 | 23/08/29 | 15,428 sh | $4.71 | $72,665.88 | −100.0% |
Brunilda ShtyllaChief Business Officer | Sutro BiopharmaSTRO | Open-market sale | 23/08/25 | 23/08/28 | 11,613 sh | $4.59 | $53,303.67 | −47.3% |